| Product Information |
BR-1413_PI_01.pdf
|
| Registration Number |
BR-1413
|
| Generic Name |
Semaglutide
|
| Brand Name |
Rybelsus
|
| Dosage Strength |
3 mg
|
| Dosage Form |
Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Glucagon-like Peptide-1 (GLP-1) Analogue
|
| Packaging |
Alu/Alu blister pack x 10's (box of 30's, 60's, and 90's)
|
| Manufacturer |
Novo Nordisk A/S
|
| Country of Origin |
Denmark
|
| Trader |
N/A
|
| Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
18 August 2022
|
| Expiry Date |
18 August 2027
|